There are a number of genetic factors that likely modulate both the benefic
ial and adverse effects of estrogen. An important domain of consideration i
s the relationship of estrogen and thrombosis risk. Gene polymorphisms amon
g the key elements of the coagulation and fibrinolytic cascade appear to in
fluence the effects of estrogen on risk for venous thromboembolic events an
d possibly arterial thrombosis as well. Emerging data also suggest that all
elic variants in the estrogen receptor-alpha may modulate estrogen's effect
s, especially with respect to bone and lipid metabolism.